According to a report,“Sepsis Diagnostics Market Analysis By Product (Instruments, Blood Culture Media, Assay Kits), By Technology (Microbiology, Molecular Diagnostics, Immunoassays), By Testing Type (Laboratory, PoC), By Pathogen, And Segment Forecasts, 2018 – 2025”, published by Grand View Research, Inc., The global sepsis diagnostics market is expected to reach a value of USD 874.6 million by 2025. Rising prevalence of sepsis is the most significant factor anticipated to drive the market growth during the forecast period.
Key Takeaways from the report:
-
Blood culture media was the largest segment in 2015 due to higher adoption of culture media tests in laboratories for the diagnosis of septic poisoning
-
Molecular diagnostics is anticipated to witness lucrative growth over the forecast period due to quick and efficient identification of microorganisms causing septicemia
-
Bacterial sepsis contributed toward the largest revenue in 2015. This is due to the fact that bacterial infection is the most common cause for people suffering from septic poisoning
-
In 2015, laboratory testing segment held the highest share due to the fact that majority of the sepsis diagnostic tests are being conducted in laboratory-based setting
-
North America dominated in 2015 owing to the increasing mortality rate of patients suffering from septicemia
-
Some of the key companies include bioMérieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Roche Diagnostics, Cepheid Inc., Beckman Coulter, Inc., Nanosphere, Inc., and Bruker Corporation
Global sepsis diagnostics market share, by product, 2015
Browse More Reports in Clinical Diagnostics:
- Cardiac Biomarkers Market: Analysis of global market trends focuses on the increasing demand for cardiac biomarkers owing to its increased adoption in cardiovascular disease diagnosis.
- Women’s Health Market: Increasing female geriatric population, introduction of various drugs related to women’s health, and favorable government policies are some of the factors expected to drive growth during the forecast period.
According to the National Center for Biotechnology Information, the number of patients suffering from septic poisoning rose by an average of 5.7% each year. As a result of this, there is a rising need for early diagnosis of such blood-poisoning diseases amongst patients. High prevalence of sepsis is also leading to a huge mortality rate, which is triggering early diagnosis to execute the clinical intervention.
UK sepsis diagnostics market, by technology, 2014-2025 (USD Million)
Rising number of hospital-acquired infections are also expected to support the growth of the market over the forecast period. Hospital-acquired infections majorly include urinary tract & surgical site infections, which result into sepsis. According to WHO, 7 out of every 100 hospitalized patients develop hospital-acquired infections in developed countries. Thus, such infections significantly cause septicemia, which will resultantly raise the need for early diagnosis. On the other hand, pneumonia is also an important driving factor for high demand of sepsis diagnostics as it is one of the major causes for septic shock.
Grand View Research has segmented the sepsis diagnostics market on the basis of product, technology, pathogen, testing type, and region:
Product Outlook (Revenue, USD Million; 2014 – 2025)
-
Instruments
-
Blood Culture Media
-
Assay Kits and Reagents
Technology Outlook (Revenue, USD Million; 2014 – 2025)
-
Microbiology
-
Molecular Diagnostics
-
Immunoassays
-
Flow Cytometry
Pathogen Outlook (Revenue, USD Million; 2014 – 2025)
-
Bacterial Sepsis
-
Gram-Positive Bacteria
-
Gram-Negative Bacteria
-
-
Fungal Sepsis
-
Others
Testing Type Outlook (Revenue, USD Million; 2014 – 2025)
-
Laboratory Testing
-
PoC Testing
Regional Outlook (Revenue, USD Million; 2014 – 2025)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
Germany
-
UK
-
-
Asia Pacific
-
China
-
India
-
-
Latin America
-
Brazil
-
Mexico
-
-
MEA
-
South Africa
Explore sepsis diagnostics market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
For more information: www.grandviewresearch.com
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: Switzerland
Website: www.grandviewresearch.com/industry-analysis/sepsis-diagnostics-market